explore -WSS

explore

author：Wikipedia 2025-08-19 12:07:50 - browse：2

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： CVS is willing to dump 10% of its Medicare Advantage members

WSS

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

WuXi Biologics beefs up its lobbying operation

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Novo Nordisk testing Wegovy against alcohol

Lilly’s weekly insulin works as well as daily products, new studies show

hotspot

explore

hotspot

Medical records are filled with copy

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

In age of alternative facts, a scholarly course on calling out crap

HIV vaccine remains elusive. Immunologists keep trying new ideas

Apple is now the first public company to be valued at $3 trillion

STAT series 'Denied by AI' wins major journalism prizes

Tori Bowie and the unacceptable rates of Black maternal death

ALS treatment from Biogen, Ionis fails in study

hotspot

WuXi Biologics beefs up its lobbying operation

Boston hospital trains restaurant workers on naloxone for overdoses

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Bird flu: Don't repeat Covid's 'health versus the economy' framing

What a koala virus tells us about the human genome

The United States must get value

entertainment

focus

focus

explore